Hologic to Showcase Developments in Next-Generation AI Solutions at RSNA 2023 - Seite 3
For more information on Hologic, visit www.hologic.com.
Forward-Looking Statements
This news release may contain forward-looking information that involves risks and uncertainties, including statements about the use of Hologic products. There can be no assurance these products will achieve the benefits described herein or that such benefits will be replicated in any particular manner with respect to an individual patient, as the actual effect of the use of the products can only be determined on a case-by-case basis. In addition, there can be no assurance that these products will be commercially successful or achieve any expected level of sales. Hologic expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any such statements presented herein to reflect any change in expectations or any change in events, conditions or circumstances on which any such data or statements are based.
Hologic, Genius AI, ImageChecker, I-View, LOCalizer, SecurView, Tuloc, Tuflex and The Science of Sure are trademarks and/or registered trademarks of Hologic, Inc., and/or its subsidiaries in the United States and/or other countries.
1 Kshirsagar, A. (2023). Comparison between ImageChecker CAD and GAID algorithm on sequestered FDA database. Refer to Hologic document (DHM-14593).
Source: Hologic, Inc.
Lesen Sie auch
View source version on businesswire.com: https://www.businesswire.com/news/home/20231124298382/en/
The Hologic Stock at the time of publication of the news with a fall of -0,09 % to 66,22EUR on Tradegate stock exchange (23. November 2023, 22:26 Uhr).